Notes from the Psychedelic Underground
The legalization of marijuana across the U.S. and Canada is making headline news. The study of the medical uses of psilocybin (and other psychedelics) does not. Academic research of psilocybin found in hallucinogenic mushrooms, lysergic acid, and ecstasy is ongoing at major universities around the world. Peer-reviewed articles on the uses of LSD for alcoholism, micro-dosing of LSD for depression, and palliative care to help the terminally ill die peacefully. The Food and Drug Administration has approved some initial clinical trials. And psychotherapists are experimenting in both clinical and clandestine settings. There is a quiet revolution in the way doctors and government officials talk and think about psychedelics. In just a few years, some of these drugs could be publicly available.
Michael Pollan, professor of journalism at the University of California at Berkeley, is a contributing writer to the New York Times Magazine. He is the bestselling author of The Omnivore’s Dilemma and In Defense of Food.